Convalescent Plasma for Outpatients with Covid-19

被引：2

作者：

Fisher, David ^{[1
]}

Malnick, Stephen ^{[1
]}

机构：

[1] Kaplan Med Ctr, Rehovot, Israel

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2021年

关键词：

THERAPY;

D O I：

10.1056/NEJMc2114591

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To the Editor: In the Covid-19 Convalescent Plasma in Outpatients (C3PO) trial,(1) Korley et al., members of the Strategies to Innovate Emergency Care Clinical Trials Network (SIREN), administered convalescent plasma to high-risk outpatients within 1 week after the onset of symptoms of Covid-19. It is unclear why the authors selected 1 week instead of a shorter time frame, since it has been shown that the 30-day and 60-day mortality benefits of convalescent plasma have been observed when it is administered within 3 days after diagnosis and that the benefit dissipates after this point.(2,3) The aim of their trial was to . . .

引用

页数：1

共 11 条

[1]

Centers for Disease Control and Prevention, Underlying medical conditions associated with higher risk for severe COVID-19: information for healthcare professionals

[2] Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium [J].

Grivas, P. ;

Khaki, A. R. ;

Wise-Draper, T. M. ;

French, B. ;

Hennessy, C. ;

Hsu, C-Y ;

Shyr, Y. ;

Li, X. ;

Choueiri, T. K. ;

Painter, C. A. ;

Peters, S. ;

Rini, B., I ;

Thompson, M. A. ;

Mishra, S. ;

Rivera, D. R. ;

Acoba, J. D. ;

Abidi, M. Z. ;

Bakouny, Z. ;

Bashir, B. ;

Bekaii-Saab, T. ;

Berg, S. ;

Bernicker, E. H. ;

Bilen, M. A. ;

Bindal, P. ;

Bishnoi, R. ;

Bouganim, N. ;

Bowles, D. W. ;

Cabal, A. ;

Caimi, P. F. ;

Chism, D. D. ;

Crowell, J. ;

Curran, C. ;

Desai, A. ;

Dixon, B. ;

Doroshow, D. B. ;

Durbin, E. B. ;

Elkrief, A. ;

Farmakiotis, D. ;

Fazio, A. ;

Fecher, L. A. ;

Flora, D. B. ;

Friese, C. R. ;

Fu, J. ;

Gadgeel, S. M. ;

Galsky, M. D. ;

Gill, D. M. ;

Glover, M. J. ;

Goyal, S. ;

Grover, P. ;

Gulati, S. .

ANNALS OF ONCOLOGY, 2021, 32 (06) :787-800

[3] Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study [J].

Hatzl, Stefan ;

Posch, Florian ;

Sareban, Nazanin ;

Stradner, Martin ;

Rosskopf, Konrad ;

Reisinger, Alexander C. ;

Eller, Philipp ;

Schoerghuber, Michael ;

Toller, Wolfgang ;

Sloup, Zdenka ;

Prueller, Florian ;

Guetl, Katharina ;

Pilz, Stefan ;

Rosenkranz, Alexander R. ;

Greinix, Hildegard T. ;

Krause, Robert ;

Schlenke, Peter ;

Schilcher, Gernot .

ANNALS OF INTENSIVE CARE, 2021, 11 (01)

[4] Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19 [J].

Hueso, Thomas ;

Pouderoux, Cecile ;

Pere, Helene ;

Beaumont, Anne-Lise ;

Raillon, Laure-Anne ;

Ader, Florence ;

Chatenoud, Lucienne ;

Eshagh, Deborah ;

Szwebel, Tali-Anne ;

Martinot, Martin ;

Camou, Fabrice ;

Crickx, Etienne ;

Michel, Marc ;

Mahevas, Matthieu ;

Boutboul, David ;

Azoulay, Elie ;

Joseph, Adrien ;

Hermine, Olivier ;

Rouzaud, Claire ;

Faguer, Stanislas ;

Petua, Philippe ;

Pommeret, Fanny ;

Clerc, Sebastien ;

Planquette, Benjamin ;

Merabet, Fatiha ;

London, Jonathan ;

Zeller, Valerie ;

Ghez, David ;

Veyer, David ;

Ouedrani, Amani ;

Gallian, Pierre ;

Pacanowski, Jerome ;

Mekinian, Arsene ;

Garnier, Marc ;

Pirenne, France ;

Tiberghien, Pierre ;

Lacombe, Karine .

BLOOD, 2020, 136 (20) :2290-2295

[5]

Joyner M J., 2020, J CLEANER PROD, VmedRxiv

[6]

KORLEY F, 2020, VIROLOGY, V551, P26

[7] Early Convalescent Plasma for High-Risk Outpatients with Covid-19 [J].

Korley, Frederick K. ;

Durkalski-Mauldin, Valerie ;

Yeatts, Sharon D. ;

Schulman, Kevin ;

Davenport, Robertson D. ;

Dumont, Larry J. ;

El Kassar, Nahed ;

Foster, Lydia D. ;

Hah, Jennifer M. ;

Jaiswal, Siddartha ;

Kaplan, Alesia ;

Lowell, Ezekiel ;

McDyer, John F. ;

Quinn, James ;

Triulzi, Darrell J. ;

Van Huysen, Carol ;

Stevenson, Valerie L. W. ;

Yadav, Kabir ;

Jones, Christopher W. ;

Kea, Bory ;

Burnett, Aaron ;

Reynolds, Joshua C. ;

Greineder, Colin F. ;

Haas, Nathan L. ;

Beiser, David G. ;

Silbergleit, Robert ;

Barsan, William ;

Callaway, Clifton W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21) :1951-1960

[8]

Salazar E, 2020, AM J PATHOL, V190, P1680, DOI [10.1016/j.ajpath.2020.10.008, 10.1016/j.ajpath.2020.05.014]

[9] Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients [J].

Vijenthira, Abi ;

Gong, Inna Y. ;

Fox, Thomas A. ;

Booth, Stephen ;

Cook, Gordon ;

Fattizzo, Bruno ;

Martin-Moro, Fernando ;

Razanamahery, Jerome ;

Riches, John C. ;

Zwicker, Jeff ;

Patell, Rushad ;

Vekemans, Marie Christiane ;

Scarfo, Lydia ;

Chatzikonstantinou, Thomas ;

Yildiz, Halil ;

Lattenist, Raphael ;

Mantzaris, Ioannis ;

Wood, William A. ;

Hicks, Lisa K. .

BLOOD, 2020, 136 (25) :2881-2892

[10] Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [J].

Wang, Dawei ;

Hu, Bo ;

Hu, Chang ;

Zhu, Fangfang ;

Liu, Xing ;

Zhang, Jing ;

Wang, Binbin ;

Xiang, Hui ;

Cheng, Zhenshun ;

Xiong, Yong ;

Zhao, Yan ;

Li, Yirong ;

Wang, Xinghuan ;

Peng, Zhiyong .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (11) :1061-1069

← 1 2 →